Partner Content Partner Content FDA releases Biosimilar Action Plan: Hear more at Biosimilar... Biosimilars USA conference information
Partner Content Partner Content SMi’s Biosimilars & Biobetters - Exclusive Interview with Dr... Biosimilars & Biobetters conference information
Events Partner Content SMi's 9th annual Biosimilars & Biobetters Biosimilars & Biobetters conference information
Events Partner Content SMi's 5th Annual Biosimilars USA Conference Biosimilars USA conference information
Partner Content Partner Content Registration is open for the 9th Annual Biosimilars & Bi... Biosimilars & Biobetters conference information
Partner Content Partner Content Agenda Released for USA Biosimilars Conference this November Agenda Released for USA Biosimilars Conference this Nov
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
